Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Express Scripts
Fuji
US Department of Justice
Cerilliant
Queensland Health
US Army
Colorcon

Generated: July 17, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Erythromycin, and when can generic versions of Erythromycin launch?

Erythromycin is a drug marketed by Arbor Pharms Llc, Barr, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Elkins Sinn, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Paddock Llc, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt Bio Ag, Mylan Pharms Inc, Amneal Pharms Co, Lyne, Tolmar, Ivax Sub Teva Pharms, Watson Labs, G And W Labs Inc, Life Labs, Ani Pharms Inc, Dista, Naska, Parke Davis, Mylan, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Lederle, and Purepac Pharm. and is included in sixty-two NDAs.

The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Drug patent expirations by year for ERYTHROMYCIN
Pharmacology for ERYTHROMYCIN
Synonyms for ERYTHROMYCIN
1334-29-8
1334-39-0
33H58I7GLQ
3847-29-8
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin (1:1)
847E298
AC1L2G7Z
AC1Q5R2M
Azithromycin lactobionate
C37H67NO13.C12H22O12
C49H89NO25
CA000798
CHEMBL1200506
CHEMBL3786307
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1)
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1) (9CI)
D02009
EINECS 223-348-7
Erythrocin Lactobionate IV
Erythromycin 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
erythromycin lactobionate
Erythromycin lactobionate (1:1) (salt)
Erythromycin lactobionate (JP17/USP)
Erythromycin lactobionate [JAN]
Erythromycin mono(4-O-beta-D-galactopyranosyl-D-gluconate) (salt)
Erythromycin, 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
ERYTHROMYCIN; LACTOBIONIC ACID
Erythromycin. compd. with lactobionic acid
ERYTHROMYCINLACTOBIONATE
Lactobionic acid compd. with erythromycin (1:1)
Lactobionic acid, compd. with erythromycin (1:1)
LS-87509
MolPort-039-062-122
n-2,10-dion(1:1)
Q-201067
SCHEMBL41566
UNII-33H58I7GLQ

US Patents and Regulatory Information for ERYTHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062089-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062087-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co ERYTHROMYCIN erythromycin TABLET;ORAL 209720-001 Mar 9, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062200-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Johnson and Johnson
Julphar
Moodys
US Department of Justice
Federal Trade Commission
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.